Spectrum Pharmaceuticals, Inc. et al v. Amneal Pharmaceuticals LLC
Filing
37
FINAL JUDGMENT in favor of Amneal that claims 1 and 2 of the '829 patent are invalid, and claims 3, 4, and 5-14 of the ' 829 patent are not infringed by ANDA No. 207547 as if fully tried and adjudicated.. Signed by Judge James C. Mahan on 6/9/16. (Copies have been distributed pursuant to the NEF - JC)
1
2
3
4
UNITED STATES DISTRICT COURT
5
THE DISTRICT OF NEVADA
6
SPECTRUM PHARMACEUTICALS, INC.
and UNIVERSITY OF STRATHCLYDE,
Case No.: 2:15-cv-00139-JCM-NJK
7
Plaintiffs,
8
[PROPOSED] ORDER
vs.
2300 WEST SAHARA AVENUE, SUITE 1200 • LAS VEGAS, NEVADA 89102
PHONE (702) 873-4100 • FAX (702) 873-9966
McDONALD • CARANO • WILSON LLP
9
AMNEAL PHARMACEUTICALS LLC
10
Defendant.
11
12
WHEREAS, on January 23, 2015, Plaintiffs Spectrum Pharmaceuticals, Inc. and
13
University of Strathclyde (collectively, “Plaintiffs”) commenced this action against Amneal
14
Pharmaceuticals, Inc. (“Amneal”), alleging infringement of U.S. Patent No. 6,500,829 (“the
15
’829 patent”) under 35 U.S.C. § 271(a), (b), (c), and (e)(2)(A) (ECF No. 1);
WHEREAS Plaintiffs and Amneal have jointly stipulated to final judgment in this
16
17
action in accordance with the Stipulation for Entry of Final Judgment.
18
NOW, THEREFORE, IT IS HEREBY ORDERED AS FOLLOWS:
19
Judgment is entered in favor of Amneal that claims 1 and 2 of the ’829 patent are
20
invalid, and claims 3, 4, and 5-14 of the ’829 patent are not infringed by ANDA No. 207547 as
21
if fully tried and adjudicated.
22
IT IS SO ORDERED:
23
UNITED STATES DISTRICT JUDGE
June 9, 2016
DATED:
24
25
26
27
360402
28
Page 1 of 1
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?